Fig. 5.
Immunoblot analysis of the left CCA with densitometry analysis for ERK 1/2 (a), caspase-3 (b), and PCNA (c) at 3 days in positive control (lane 1), sham (lane 2), control (lane 3) and HSV-1 R7020-treated (lane 4) groups.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.